We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$67.3B
AUM Growth
+$5.83B
(+9.5%)
Cap. Flow
+$4.68B
Cap. Flow
% of AUM
6.96%
Top 10 Holdings %
Top 10 Hldgs %
59.38%
Holding
194
New
31
Increased
78
Reduced
36
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$366M |
| 2 |
Expedia Group
EXPE
|
+$342M |
| 3 |
Netflix
NFLX
|
+$292M |
| 4 |
Lyft
LYFT
|
+$284M |
| 5 |
Burlington
BURL
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bilibili
BILI
|
+$344M |
| 2 |
Alibaba
BABA
|
+$294M |
| 3 |
Pinterest
PINS
|
+$245M |
| 4 |
Sea Limited
SE
|
+$237M |
| 5 |
Salesforce
CRM
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Consumer Discretionary | 6.89% |
| 3 | Communication Services | 4.08% |
| 4 | Financials | 2.92% |
| 5 | Healthcare | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Dolby
DLB
$5.83B
| $29.6M | 0.04% |
300,000
| – | – |
|
|
MRSN
127
DELISTED
Mersana Therapeutics
MRSN
| $29.3M | 0.04% |
72,420
+227
| +0.3% | +$110K |
|
128
Karyopharm Therapeutics
KPTI
$44.4M
| $28.1M | 0.04% |
177,880
+119
| +0.1% | +$25.1K |
|
|
KLRS
129
Kalaris Therapeutics
KLRS
$94.2M
| $25.7M | 0.04% |
47,696
| – | – |
|
130
PUT
Weibo
WB
$1.97B
| $25.4M | 0.04% |
502,800
+1,500
| +0.3% | +$75.7K |
|
|
MORF
131
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $24.8M | 0.04% |
392,000
+242,000
| +161% | +$11.1M |
|
132
Oric Pharmaceuticals
ORIC
$1.37B
| $24.5M | 0.04% |
998,061
+100,000
| +11% | +$3.16M |
|
133
Zoom
ZM
$31.4B
| $24.4M | 0.04% |
76,000
+16,000
| +27% | +$5.89M |
|
134
CALL
Match Group
MTCH
$8.43B
| $24M | 0.04% |
175,000
| – | – |
|
|
CERE
135
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $24M | 0.04% |
1,750,000
| – | – |
|
|
APLT
136
DELISTED
Applied Therapeutics
APLT
| $19.5M | 0.03% |
1,041,334
+301,781
| +41% | +$6.51M |
|
|
RNAM
137
DELISTED
Avidity Biosciences
RNAM
| $19.1M | 0.03% |
875,000
| – | – |
|
138
4D Molecular Therapeutics
FDMT
$580M
| $17.5M | 0.03% |
402,926
+1,041
| +0.3% | +$46.1K |
|
139
Datadog
DDOG
$92.2B
| $17.1M | 0.03% |
204,730
-10,270
| -5% | -$990K |
|
140
Stem
STEM
$48.2M
| $14.6M | 0.02% |
+27,500
| New | +$17.7M |
|
141
Elastic
ESTC
$7.97B
| $13.9M | 0.02% |
125,000
+45,000
| +56% | +$6.39M |
|
142
NetEase
NTES
$85B
| $10.9M | 0.02% |
105,095
-957,040
| -90% | -$108M |
|
143
Zillow
ZG
$7.52B
| $10.5M | 0.02% |
+80,000
| New | +$12.3M |
|
|
YSG
144
Yatsen Holding
YSG
$313M
| $10.5M | 0.02% |
169,534
-141,171
| -45% | -$12.8M |
|
|
ATC
145
DELISTED
Atotech Limited
ATC
| $6.6M | 0.01% |
+325,900
| New | +$6.67M |
|
|
MREO
146
Mereo BioPharma
MREO
$45.3M
| $6.52M | 0.01% |
1,935,600
| – | – |
|
147
Restaurant Brands International
QSR
$25.4B
| $6.5M | 0.01% |
100,000
-1,108,776
| -92% | -$68.7M |
|
148
Neurogene
NGNE
$711M
| $6.16M | 0.01% |
25,000
| – | – |
|
149
Sony
SONY
$140B
| $5.83M | 0.01% |
+275,000
| New | +$5.81M |
|
150
CrowdStrike
CRWD
$231B
| $5.47M | 0.01% |
120,000
-400,000
| -77% | -$21.2M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Alkeon Capital Management held 194 positions worth $67.3B, up 9.5% from $61.4B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Alkeon Capital Management deployed $4.68B of net new capital in Q1 2021, opening 31 new positions and adding to 78 existing holdings. Its largest new stake was Uber: 6,550,000 shares worth $357M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Bilibili, an estimated $344M trimmed.
- Alkeon Capital Management's largest Q1 2021 buy was Uber: 6,550,000 shares worth $357M.
- Alkeon Capital Management added most to PayPal in Q1 2021, an estimated $202M increase.
- Alkeon Capital Management's biggest Q1 2021 reduction was Bilibili, cutting an estimated $344M.
- Alkeon Capital Management fully exited Salesforce in Q1 2021, selling an estimated $212M.
- Alkeon Capital Management's ten largest holdings make up 59% of its $67.3B portfolio in Q1 2021.
- Alkeon Capital Management opened 31 new positions and closed 20 in Q1 2021.
- Alkeon Capital Management's portfolio value rose 9.5% quarter-over-quarter to $67.3B.
Based on Alkeon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.